DiaMedica Therapeutics (DMAC) Receivables - Accured (2019 - 2026)
DiaMedica Therapeutics (DMAC) recorded Receivables - Accured of $236,000 in Q2 2026, up 66.2% from $142,000 a year earlier but down 17.2% from the prior quarter.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Receivables - Accured (2019 - 2026) Analysis & Trends
At the end of FY2025, DiaMedica Therapeutics reported Receivables - Accured of $250,000, up 6.4% from FY2024.
- Annual Receivables - Accured has a five-year compound annual growth rate of 49.0% (FY2020 to FY2025).
- Across earlier years, Receivables - Accured came in at $235,000 in FY2024 (-21.1%), $298,000 in FY2023 (+272.5%), $80,000 in FY2022 (-38.5%) and $130,000 in FY2021 (+282.4%).
- Quarterly Receivables - Accured has ranged from $55,000 in Q1 2023 to $391,000 in Q1 2024 over the past five years.
- On a year-over-year basis, Receivables - Accured has increased for three consecutive quarters, with an average decline of 7.1% over the last eight quarters.
- Peak year-over-year performance for Receivables - Accured in the last five years was growth of 877.8% in Q2 2022, against a decline of 66.9% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $285,000 (Q1 2026), $250,000 (Q4 2025) and $228,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | DiaMedica Therapeutics | 445.97 Mn | 445.97 Mn | - | 236,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 236,000.00 |
| Mar 31, 2026 | 285,000.00 |
| Dec 31, 2025 | 250,000.00 |
| Sep 30, 2025 | 228,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Dec 31, 2024 | 235,000.00 |
| Sep 30, 2024 | 288,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 391,000.00 |
| Dec 31, 2023 | 298,000.00 |
| Sep 30, 2023 | 309,000.00 |
| Jun 30, 2023 | 186,000.00 |
| Mar 31, 2023 | 55,000.00 |
| Dec 31, 2022 | 80,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 88,000.00 |
| Mar 31, 2022 | 166,000.00 |
| Dec 31, 2021 | 130,000.00 |
| Sep 30, 2021 | 102,000.00 |
API Access
DiaMedica Therapeutics Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();